EROAD Earnings Call Transcripts
Fiscal Year 2026
-
Revenue grew 3.3% to $99.1 million, with normalized free cash flow at $16.7 million and strong ARR growth. A $134.7 million North American impairment drove a net loss, but liquidity and cash generation remain robust. Focus is on ANZ growth and ERUC opportunities.
Fiscal Year 2025
-
FY 2025 saw a return to profitability, strong free cash flow, and strategic progress, with growth in ARR and revenue despite industry headwinds. Board renewal, AI-driven innovation, and disciplined investment underpin future plans, while governance and stakeholder engagement remain priorities.
-
Revenue grew 7% to $194.4M and normalized EBIT rose 161% to $9.9M, with free cash flow at $16M. FY 2026 guidance targets at least $205M revenue and 8–10% free cash flow yield, with growth led by North America and enterprise customers.
-
Revenue grew 8% to NZD 95.9M, with EBIT up to NZD 2.4M and normalized free cash flow at NZD 6.2M. ARR reached NZD 178M, driven by product innovation and enterprise expansion. On track for FY 2025 guidance, with strong liquidity and no plans for capital raise.
Fiscal Year 2024
-
The meeting highlighted strong FY 2024 financial results, major cost reductions, and a strategic focus on AI-driven innovation and North American expansion. Board composition was refreshed, governance practices enhanced, and shareholders approved director elections and auditor reappointment.